Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury.
about
Transplantation of specific human astrocytes promotes functional recovery after spinal cord injuryTransplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injuryBMP signaling in axon regenerationPrecursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injuryThe multifaceted effects of agmatine on functional recovery after spinal cord injury through Modulations of BMP-2/4/7 expressions in neurons and glial cellsiPS cell transplantation for traumatic spinal cord injuryTransplanted glial restricted precursor cells improve neurobehavioral and neuropathological outcomes in a mouse model of neonatal white matter injury despite limited cell survival.Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury.Dynamic behaviors of astrocytes in chemically modified fibrin and collagen hydrogels.Niche-dependent development of functional neuronal networks from embryonic stem cell-derived neural populations.Overexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury.Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats.Effect of type-2 astrocytes on the viability of dorsal root ganglion neurons and length of neuronal processes.Altered cytokine gene expression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: a case-control study.BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injuryGrafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cordTransplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.Therapeutically targeting astrocytes with stem and progenitor cell transplantation following traumatic spinal cord injuryDirected differentiation of functional astroglial subtypes from human pluripotent stem cells.Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injuryHuman iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury.Phenotypic analysis of astrocytes derived from glial restricted precursors and their impact on axon regenerationPermissive Schwann cell graft/spinal cord interfaces for axon regenerationSafety of epicenter versus intact parenchyma as a transplantation site for human neural stem cells for spinal cord injury therapy.Human astrocytes derived from glial restricted progenitors support regeneration of the injured spinal cordAmelioration of motor/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation.Glial-Restricted Precursors Protect Neonatal Brain Slices from Hypoxic-Ischemic Cell Death Without Direct Tissue ContactValidity of acute and chronic tactile sensory testing after spinal cord injury in rats.Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.Bridging spinal cord injuries.Safety of human neural stem cell transplantation in chronic spinal cord injury.hESC-derived Olig2+ progenitors generate a subtype of astroglia with protective effects against ischaemic brain injury.Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons.Stem cell therapies for spinal cord injuryTargeting astrocyte signaling for chronic pain.Mesenchymal stem cells for treatment of CNS injury.Transforming growth factor-β in normal nociceptive processing and pathological pain models.Building biocompatible hydrogels for tissue engineering of the brain and spinal cordConcise review: reactive astrocytes and stem cells in spinal cord injury: good guys or bad guys?Stem and Progenitor Cell-Derived Astroglia Therapies for Neurological Diseases.
P2860
Q21135533-33F33044-4537-4ECF-9562-9AC634AF5020Q26825854-21433035-AFEE-4C4B-A2D5-8581AB73A76AQ26852511-9565A242-A380-48EF-B30E-1B86997E460AQ27004382-789E89CE-9AE3-4F28-B8A0-D5CC25EEEC40Q27320717-8F792027-C03B-4BBE-BF3E-340F1A54CCCAQ28087189-8F46D08C-21D3-4A26-B8A3-A7E032E12C22Q30389642-F3E96C36-01EF-40DD-B52E-420E80D3A857Q30499309-C42D77F1-B136-44B8-9073-A6006F3958C9Q30757657-5C0D0F12-0731-4E8C-8D49-D658B8A327F9Q33491268-D3CFB35D-4AE3-4E47-B3E4-85D76A4BB0C3Q33671711-A15DA340-85A8-4517-8917-AF3F5F5677D1Q33955348-005FB450-1680-4CB9-812B-FF6E4FE76989Q34095690-D8349C11-1928-4988-807A-AF96953E342CQ34580026-AEAF968D-952A-4A29-9075-700F28D73623Q34979181-35ED8EB1-6EAE-44CE-933F-8DD6483890BEQ35142642-9FEDA345-89F0-4458-9A0A-12D79B80BE5AQ35153113-7554FE15-141B-4033-A255-9E3ECC25D3DAQ35205605-C4024DF4-09D2-460A-8D6C-27C0EE56A374Q35414493-340A8EEA-7D60-44BF-8312-E0B0A958F428Q35543006-43A52553-91B2-47B0-8E88-8E27A100AB81Q35717943-F02C141C-33D7-452C-9B52-D35C3CF1C976Q35737051-60B991AE-C188-47C2-A602-B2ED6A05F5B2Q36732770-387E8F61-530D-42B7-9D0D-AEA168FECF8DQ36861781-28EB8634-9C70-488B-9962-33D17A62325CQ36947673-BCAC5D2D-5530-4FE2-B2DF-54A512058EC6Q36998177-22595CC1-3358-46A2-A434-4695D8545C21Q37061164-C6E6A2A4-5387-47A9-A190-E90D8AA58768Q37065365-D2476BCB-048E-4430-B29B-A6DCE277FB08Q37231529-96E8736F-5E91-41D4-BD50-459D39CBD522Q37306832-4B03FD07-98AF-4A14-BB9F-0BDC49C78396Q37344279-775879B6-C178-4D97-A69D-2B7E9F1C0AEEQ37519454-78D851F3-2AFC-4DFC-B77E-CA35D9069F1BQ37710820-43C3EEC8-EC6D-424C-8DBF-127E549B4AC9Q37765474-B02ADE6E-A334-43FE-A3C4-B2ECAC2C3B72Q37794396-08DB6342-41F6-475B-8C82-096496DFFE94Q37883047-5663638F-17C7-4F3B-92A9-1858DD8B3643Q37962474-FF59A590-D430-431C-9BCB-3D57C9581479Q38222477-9576AA5A-A2E5-4164-A6E9-642FF0D2FAFCQ38366449-B515BBE4-0759-49FC-BE24-1BCE4C561942Q38600832-CC7B8B6B-5FC4-477C-9AB8-0578F9542AA6
P2860
Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transplanted astrocytes derive ...... ynia after spinal cord injury.
@en
Transplanted astrocytes derive ...... ynia after spinal cord injury.
@nl
type
label
Transplanted astrocytes derive ...... ynia after spinal cord injury.
@en
Transplanted astrocytes derive ...... ynia after spinal cord injury.
@nl
prefLabel
Transplanted astrocytes derive ...... ynia after spinal cord injury.
@en
Transplanted astrocytes derive ...... ynia after spinal cord injury.
@nl
P2093
P2860
P356
P1433
P1476
Transplanted astrocytes derive ...... ynia after spinal cord injury.
@en
P2093
Christoph Pröschel
Jeannette E Davies
Margot Mayer-Pröschel
Mark Noble
Ningzhe Zhang
Stephen J A Davies
P2860
P2888
P356
10.1186/JBIOL85
P577
2008-09-19T00:00:00Z
P5875
P6179
1034184668